# Identification of Potential Biomarkers of Peptide Immunotherapy. Part 1 - Proteomics Analysis

> **NCT01383590** · PHASE1 · COMPLETED · sponsor: **Circassia Limited** · enrollment: 10 (actual)

## Conditions studied

- Cat Allergy

## Interventions

- **BIOLOGICAL:** Cat-PAD

## Key facts

- **NCT ID:** NCT01383590
- **Lead sponsor:** Circassia Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2014-01-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01383590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01383590, "Identification of Potential Biomarkers of Peptide Immunotherapy. Part 1 - Proteomics Analysis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01383590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*